skip to main content

BAP1 Syndrome — SCE Medical Oncology MCQ

Instant feedback + full explanation. One question, done properly.

HardCancer GeneticsBAP1 SyndromeSCE Medical Oncology

A patient due to start capecitabine finished brivudine for herpes zoster 10 days ago. DPYD testing is normal. What is the safest SmPC-aligned action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: CDelay capecitabine until at least 4 weeks after the last brivudine dose

Brivudine potently inhibits DPD and can cause fatal fluoropyrimidine toxicity. The capecitabine SmPC requires at least a four-week interval after brivudine; a normal germline DPYD test does not neutralise acquired enzyme inhibition. Intravenous fluorouracil shares the interaction, and empirical dose reduction is not an acceptable substitute for the waiting interval.

Reference: Capecitabine UK SmPC. https://www.medicines.org.uk/emc/product/14545/smpc